NICORETTE - 0135-0514-03 - (nicotine polacrilex)

Alphabetical Index


Drug Information of NICORETTE

Product NDC: 0135-0514
Proprietary Name: NICORETTE
Non Proprietary Name: nicotine polacrilex
Active Ingredient(s): 2    mg/1 & nbsp;   nicotine polacrilex
Administration Route(s): ORAL
Dosage Form(s): LOZENGE
Coding System: National Drug Codes(NDC)

Labeler Information of NICORETTE

Product NDC: 0135-0514
Labeler Name: GlaxoSmithKline Consumer Healthcare LP
Product Type: HUMAN OTC DRUG
FDA Application Number: NDA021330
Marketing Category: NDA
Start Marketing Date: 20101019

Package Information of NICORETTE

Package NDC: 0135-0514-03
Package Description: 108 LOZENGE in 1 CONTAINER (0135-0514-03)

NDC Information of NICORETTE

NDC Code 0135-0514-03
Proprietary Name NICORETTE
Package Description 108 LOZENGE in 1 CONTAINER (0135-0514-03)
Product NDC 0135-0514
Product Type Name HUMAN OTC DRUG
Non Proprietary Name nicotine polacrilex
Dosage Form Name LOZENGE
Route Name ORAL
Start Marketing Date 20101019
Marketing Category Name NDA
Labeler Name GlaxoSmithKline Consumer Healthcare LP
Substance Name NICOTINE
Strength Number 2
Strength Unit mg/1
Pharmaceutical Classes

Complete Information of NICORETTE


General Information